Form 144: Insider sales for XERS

XERS filed a Form 144 reporting Rule 144 sales by Beth P. Hecht.

Rhea-AI Filing Summary

XERS filed a Form 144 reporting Rule 144 sales by Beth P. Hecht. The notice lists two 10b5-1 sales of 16,667 common shares each on 01/02/2026 and 02/02/2026, with gross proceeds of $123,775.48 and $124,147.15 respectively. The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the XERS Form 144 disclose about insider sales?

The Form 144 disclosed two 10b5-1 sales by Beth P. Hecht of 16,667 shares each. The entries show sales on 01/02/2026 and 02/02/2026 with proceeds of $123,775.48 and $124,147.15 respectively.

Who executed the trades reported in the XERS Form 144?

The trades were executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists that broker and the address shown alongside the 10b5-1 sales entries.

Were the sales reported as 10b5-1 plan transactions in the XERS filing?

Yes. The Form 144 entries are labeled as 10b5-1 sales for Beth P. Hecht, indicating the reported transactions were executed under a trading plan established under Rule 10b5-1.

How many total shares did Beth P. Hecht sell according to this Form 144?

The filing lists two sales of 16,667 common shares each, totaling 33,334 shares reported in the provided excerpt. Each sale includes its gross proceeds amount in dollars.

Does the Form 144 state who received the sale proceeds?

The excerpt shows gross proceeds amounts for each sale but does not state the recipient of proceeds beyond identifying the selling person. The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:36 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001652410
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	XERIS BIOPHARMA HOLDINGS, INC.
SEC File Number	001-40880
Address of Issuer	1375 West Fulton Street, Suite 1300 Chicago ILLINOIS 60607
Phone	8444455704
Name of Person for Whose Account the Securities are To Be Sold	BETH HECHT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	66668	408008.16	165924289	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/03/2024	Restricted Stock Units	Issuer			66668	01/03/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BETH P HECHT 1375 West Fulton Street, Suite 1300 Chicago IL 60607	Common	02/02/2026	16667	124147.15
10b5-1 Sales for BETH P HECHT 1375 West Fulton Street, Suite 1300 Chicago IL 60607	Common	01/02/2026	16667	123775.48

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units on 01/03/2024 and 01/31/2024.
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Beth P. Hecht
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)